Forteo
NDC Package 0002-8971-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Forteo is teriparatide is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Marketed by Eli Lilly And Company, this product is identified by NDC 0002-8971 and is authorized under FDA application NDA021318.

Identification & Billing

NDC Package Code
0002-8971-01
Package Description
1 SYRINGE in 1 CARTON / 3 mL in 1 SYRINGE
Product Code
0002-8971
11-Digit Billing Format
00002897101

Clinical Specifications

Proprietary Name
Forteo
Dosage Form
-
Usage Information
Teriparatide is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. It is similar to a natural hormone in your body (parathyroid hormone). It works by increasing bone mass and strength. This effect helps to decrease the risk of getting a fracture. This medication is not recommended for use in children or young adults whose bones are still growing.

Regulatory & Marketing

Labeler Name
Eli Lilly And Company
FDA Application #
NDA021318
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-05-2002
End Marketing Date
08-13-2010
Listing Expiration
08-13-2010
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0002-8971). Click a package code to view its specific billing and regulatory data.

0002-8971-99
1 SYRINGE in 1 CARTON / 3 mL in 1 SYRINGE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0002-8971-01 identifies a specific commercial package of 1 syringe in 1 carton / 3 ml in 1 syringe of Forteo, labeled by Eli Lilly And Company. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Eli Lilly And Company on December 05, 2002. The current certification is valid through August 13, 2010.

What are the primary indications for this medication?

Teriparatide is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. It is similar to a natural hormone in your body (parathyroid hormone). It works by increasing bone mass and strength. This effect helps to decrease the risk of getting a fracture. This medication is not recommended for use in children or young adults whose bones are still growing.

How is this Eli Lilly And Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00002897101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0002-8971-01
11-Digit CMS (5-4-2)
00002-8971-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.